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 CURRENTOPINION New frontiers in intravital microscopy of the kidney
Andrew M. Hall a,b, Claus D. Schuha, and Dominik Haenni a,c
Purpose of review
Intravital imaging with multiphoton microscopy enables the detailed study of dynamic cellular processes
within functioning organs in living animals, in ways that would not otherwise be possible. It therefore
represents a powerful tool in translational kidney research. In this article, we will discuss several new
technical developments that have significantly increased the capabilities of kidney imaging.
Recent findings
Important contemporary advances in biomedical imaging technology include longer wavelength excitation
lasers, far-red emitting fluorescent reporters, highly sensitive detectors, fluorescence lifetime measurements,
adaptive optics, microendoscopes, high-throughput automated analysis algorithms and tissue clearing
techniques. Several recent studies have utilized intravital microscopy to gain valuable new insights into
important physiological and pathophysiological processes in the kidney, such as renal handling of albumin
and the cellular pathogenesis of acute kidney injury in sepsis.
Summary
Major technological advances are rapidly expanding the frontiers of intravital microscopy, which is likely
to play an increasingly important role in preclinical kidney research in the coming years.
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INTRODUCTION
Intravital fluorescence microscopy offers the tanta-
lizing prospect of visualizing dynamic cellular proc-
esses at high resolution within functioning organs
in a living animal and how they are altered in disease
states. Multiphoton microscopy (MPM) is a form of
fluorescence imaging that uses a long wavelength
pulsed excitation laser (typically in the range 700–
1000nm), relying on the basic principle that two or
more low-energy photons arriving simultaneously
can excite a fluorescent molecule [1]. It has signifi-
cant advantages over conventional confocal micro-
scopy when working with intact tissues, including
increased depth of imaging and decreased photo-
toxicity. Intravital imaging with MPM is a powerful
and rapidly expanding technique in preclinical
research, which is driving a much-needed renais-
sance in whole animal physiology [2–5]. In this
article, we will first summarize some important
recent technical advances that have significantly
broadened the scope of intravital microscopy and
will then discuss how these are yielding important
new insights into kidney function and diseases.
NEW FRONTIERS IN IMAGING
TECHNOLOGY
The capabilities of biological imaging with MPM
have rapidly expanded in the last few years, due
to parallel advances in several distinct, but related,
fields. Major new developments include (but are not
limited to) longer wavelength excitation lasers,
highly sensitive detectors, automated microscopes
capable of running independently over days, micro-
endoscopes, tissue clearing techniques to increase
transparency, exponential increases in compu-
tational power, software algorithms that can per-
form high-throughput and unbiased automated
analysis with large data sets, an ever expanding
range of functional reporters (many of which with
ratio-metric readouts for increased reliability) and
increasing availability of ‘off the shelf’ genetically
modified animals stably expressing fluorescent mol-
ecules. A separate detailed discussion of each of
these advances is beyond the scope of this article,
but in general they are all characteristic of the wider
technological revolution that is both shaping and
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defining the early part of the 21st century. Although
their collective impact on intravital kidney imaging
is yet to be fully realized, some important recent
publications already provide clear pointers of what
will become possible in the near future.
Long wavelength excitation
Arguably, the biggest practical constraint in intra-
vital kidney imaging to date – at least in comparison
with organs such as the brain – has been the limited
depth of imaging possible. Typically, high-resol-
ution images can only be acquired down to about
50mm below the capsule [6], limiting the working
area to the very outer cortex. Crucially, this means
that important structures like glomeruli and early
tubular segments cannot be routinely visualized,
except in certain inbred strains of rat (which are
prone to developing proteinuria and hypertension).
The reason(s) why the kidney is so optically dense
is(are) not fully understood, but probably relate to
issues such as light scattering and optical aberrations
(perhaps due to high blood flow) and a high back-
ground level of autofluorescence. The scattering of
light in tissues is wavelength-dependent, and we
have recently shown that by increasing the exci-
tation wavelength (up to 1300nm), it is possible to
image significantly further into the kidney and
visualize deeper glomeruli (Fig. 1) [7
&&
]. Moreover,
autofluorescence is markedly lower at higher exci-
tation wavelengths, meaning that when working
with increasingly available far-red fluorescent
probes, a much higher signal-to-background ratio
can be achieved, which is important for high-resol-
ution imaging of small structures. Other advantages
of this approach include the possibility to image up
to four different fluorescent probes with clear
spectral separation (i.e. blue/green/red/far red)
(Fig. 2) and also to elicit second harmonic-generated
(SHG) and third harmonic-generated signals from
important biological structures, like collagen and
KEY POINTS
 Multiphoton microscopy enables the detailed study of
dynamic cellular processes in the kidney in living
animals.
 Multiple recent technical advances are combining to
greatly increase the capabilities of intravital microscopy
and image analysis.
 Recent studies have utilized intravital microscopy to
make important new insights into physiological and
pathophysiological processes in the kidney, such as
renal albumin handling and the pathogenesis of acute
kidney injury in sepsis.
 Intravital microscopy is likely to play an increasingly
important role in translational kidney research in
the future.
(a)
(b)
FIGURE 1. Intravital multiphoton kidney imaging with long
wavelength excitation. The usage of long wavelength
excitation and far-red probes allows deeper imaging in the
mouse kidney than previously possible and the visualization
of glomeruli. (a) Example of a three-dimensional rendered
image acquired from a mouse injected with Alexa Fluor 647-
labelled albumin excited at 1180nm, showing two entire
glomeruli and surrounding peritubular capillaries. The total
stack was constructed from 125 individual two-dimensional
images acquired at 1mm z intervals. Scale bar¼30mm.
(b) A single plane is depicted from the above stack at a
depth of 65mm showing detailed morphology of glomerular
capillaries. Scale bar¼10mm.
Intravital kidney microscopy Hall et al.
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lipids, respectively [8]. Meanwhile, advances in
image analysis software, including image deconvo-
lution and rendering, mean that serial two-dimen-
sional images taken through the kidney can be used
to reconstruct detailed three-dimensional architec-
ture in living tissue (Fig. 1).
Adaptive optics
Although longer wavelength excitation clearly
increases the depth of imaging possible in the kid-
ney, it still remains far short of what can be achieved
in other less optically dense organs, and there is a
clear need for new and innovative solutions to this
problem. Adaptive optics is a method that attempts
to correct for aberrations produced by differences in
the optical density in a specimen by measuring
distortions in a wavefront, which can then be com-
pensated for. It is widely used in astronomy, and its
potential application to intravital imaging is
increasingly being explored. However, compensat-
ing for aberrations in intact functioning organs,
within which irregular dynamic processes like
blood flow are occurring, represents a huge tech-
nical challenge. Nevertheless, a recent publication
has suggested that the usage of adaptive optics can
increase the effective imaging depth in the mouse
brain to around 700mm [9].
Transgenic animals expressing fluorescent
proteins
To harness the full potential of intravital imaging for
preclinical research, advances in hardware and soft-
ware need to be matched by improvements in
animal models. In the last few years, there has been
an explosion in the number of new fluorescent
sensors available to study key cellular processes;
however, the usage of most of these is effectively
confined at present to in-vitro experiments. In con-
trast, the range of signals that can currently be
imaged in the kidney in vivo is far more limited. A
major reason for this is that strategies used routinely
in other organs to genetically express fluorescent
sensors, such as bulk injection of viral vectors, have
not proven successful in the kidney (although a
recent study has suggested that injection via the
renal vein could yield better results [10]). A more
promising strategy is to genetically modify animals
so that they express stable or inducible fluorescent
reporters in cells of interest. This approach has been
used recently to perform the very first intravital
studies of Ca2þ signals in the nephron [11,12&&],
which revealed several important new findings,
including the fact that intracellular Ca2þ increases
in podocytes in glomerular disease models.
Although some physiological events, such as
Ca2þ signals, occur within seconds, other important
processes take days or even weeks, timescales that
are beyond the typical intravital imaging window of
several hours. Repetitive imaging experiments are
routinely performed in the brain by using an optical
window, placed in an area of removed skull. Similar
attempts to create windows in the abdomen have
FIGURE 2. Simultaneous imaging of four different signals
in the kidney. The broad-spectrum multiphoton excitation
range of many fluorescent molecules and the addition of a
far-red channel enables simultaneous imaging of multiple
different probes with clear signal separation. In the
example depicted, a mouse was injected with Cascade Blue
Dextran (blue, a marker of endocytosis in the proximal
tubule), Rhodamine 123 (green, a mitochondrial marker),
Lysotracker (red, a lysosomal marker) and Alexa Fluor 647-
labelled albumin (purple, a vascular marker). Scale
bar¼10mm.
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been attempted [13], but are not as yet widely used.
However, a recent study has shown that repetitive
kidney imaging can be performed by simply replac-
ing the kidney back within the abdominal compart-
ment after each experiment [14]. When combined
with podocin-confetti mice (which express either
Cyan fluorescent protein (CFP), green fluorescent
protein (GFP), yellow fluorescent protein (YFP), or
red fluorescent protein (RFP) in individual podo-
cytes), this approach allowed serial tracking of the
same cells over several days and revealed the import-
ant finding that podocytes appear to migrate into
the parietal layer in disease models. A study from
another group also using podocyte-confetti mice
has confirmed that podocytes appear relatively
stationary under normal conditions, but show
dramatic dynamic changes in disease models,
including retraction of foot processes, detachment
from the glomerulus and crawling along the tubular
epithelium [15
&&
].
Traditionally, the generation of new genetically
modified mouse lines has required significant
investment of resources, but this is likely to become
considerably quicker and easier in the future due to
developments in genetic engineering. For example,
the generation of knockout disease models has been
greatly simplified by the recent discovery of the
Clustered regularly interspaced short palindromic
repeats Cas9 (CRISPR/Cas9) system. Genetic expres-
sion of fluorescent proteins is already routinely
performed in zebrafish, which are ideally suited to
intravital imaging due to their relative transparency.
Such approaches have been utilized previously to
perform studies of podocyte dynamics [16] and
injury in disease models [17]. However, although
there are obvious experimental advantages to the
zebrafish model, these have to be weighed against
the physiological distance between fish and human
nephrons, and hence the translational relevance of
data obtained.
Microendoscopy
Intravital imaging with a conventional MPM set-up
is currently an invasive procedure and certainly not
yet applicable to humans. However, the develop-
ment of endoscopic microscopes offers the possib-
ility to perform intravital imaging in a minimally
invasive way. There is currentlymuch interest in the
potential usage of such instruments to perform
‘virtual biopsies’ in humans, whereby the histologi-
cal nature of suspicious lesions could be assessed
in situ [18]. It has recently been demonstrated that
endoscopic microscopy can also be used to image
the kidney in living anaesthetized mice [19], and
although the quality of images that can be acquired
is not as high as conventional MPM, this approach
could clearly be advantageous for repetitive imaging
studies in the same animal, perhaps even when
awake.
Fluorescence lifetime imaging
Many fluorophores have overlapping emission
spectra, which can lead to bleed through of signals
andmake clear spectral separation challenging. One
possible solution to this problem is to measure the
time decay of fluorescence (the lifetime), which is
unique to each fluorophore and its microenviron-
ment. Fluorescence lifetime imaging (FLIM) with
MPM has been established for some time and can
be used to distinguish important endogenous fluo-
rophores, like Nicotinamide adenine dinucleotide
(NADH) and NADPH, which have virtually identical
excitation/emission spectra, but very different phys-
iological roles. Moreover, as the lifetime of these
molecules changes when they are bound or free,
FLIM can be used to make measurements of cellular
metabolism [20]. Although FLIM has been used in
intravital studies of organs like the skin [21] and
liver [22], it is yet (to our knowledge) to be applied to
the kidney. The prerequisite for both a very high
level of tissue stability and sufficiently bright signal,
to accurately measure fluorescence decay over time,
couldmake FLIM challenging in the kidney in living
animals. However, if these technical hurdles can be
overcome, FLIM could in principle offer some clear
advantages, given the high level of endogenous
autofluorescence in the kidney. In the meantime,
a recent study using fixed specimens from a ureteric
ligation model of chronic kidney disease has shown
that FLIM can be used to separate autofluorescence
and SHG signals [23
&
]. As the latter arise from colla-
gen, this allows quantification of the extent of fib-
rosis within the specimen, without the need for any
special stains.
Tissue clearing techniques
Although not strictly speaking an intravital tech-
nique, there is nevertheless huge interest currently
in the application of tissue clearing techniques to
whole organ imaging. The basic principle of this
approach is to render fixed tissues transparent by
removing lipid components and by increasing the
refractive index of the solvent, whilst retaining
proteins and fluorescent markers. The breakthrough
demonstration of this technique was in the brain,
using the so-called CLARITY protocol [24], and
numerous examples have followed since. A recent
study from Klingberg et al. [25
&
] has nicely shown
the potential of tissue clearing for kidney imaging.
They used fluorescently labelled antibodies to stain
Intravital kidney microscopy Hall et al.
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capillaries in the mouse kidney, which enabled
visualization of glomeruli. Using tissue clearing,
they were then able to image through the entire
organ. By using a particular type of fluorescence
imaging particularly suited to rapid three-dimen-
sional imaging (called light-sheet microscopy),
and automated image processing, they could
quantify the number and volume of glomeruli in
the whole kidney. As antibody staining of proteins
of interest remains a backbone of renal research,
tissue clearing techniques could clearly have an
important future role in enabling routine three-
dimensional analysis of expression patterns. How-
ever, effective labelling of antigens in an intact
organ and preservation of binding during the clear-
ing process still remain significant technical barriers
in many cases, and further methodological refine-
ments are required in this field.
NEW FRONTIERS IN UNDERSTANDING OF
KIDNEY (PATHO)PHYSIOLOGY
As the technical frontiers of intravital imaging
march forward ever more quickly, so too inevitably
will the limits of understanding of whole organ
physiology. Intravital microscopy has provided
numerous fascinating new insights in translational
kidney research in the last decade [3]. In the follow-
ing sections, we will highlight two particularly
important subject areas in which imaging has
recently made a real impact.
Renal handling of albumin
The hallmark of many kidney diseases is an increase
in urinary excretion of albumin, which is widely
associated with both accelerated decline of renal
function and increased risk of cardiovascular disease
[26]. Moreover, albuminuria is often used as a bio-
marker or surrogate endpoint in clinical studies.
There is, therefore, much interest in studying how
exactly the kidney handles albumin. The classical
view – driven largely by older invasive micropunc-
ture studies – is that only a relatively small amount
of albumin is filtered, due to its size and negative
charge [27]. However, more recent intravital imag-
ing studies have challenged this paradigm, with the
observation that fluorescently labelled albumin
injected systemically rapidly appears in the apical
part of cells in the proximal tubule, implying that
tubular reuptake plays a far more important role
than previously appreciated [28]. It has also been
proposed, partly on the basis of imaging studies,
that albumin may be trafficked directly across prox-
imal tubule cells and back into the blood stream
[29,30]. These surprising findings have huge
implications for clinical practice and have inevita-
bly generated much controversy; the picture is fur-
ther complicated by the fact that different groups
using the same imaging techniques have reported
very different values for the glomerular sieving coef-
ficient [31,32].
Resolving these major discrepancies will not be
easy; as with most polarized debates, it seems likely
that the truth lies somewhere in between the two
extreme opposing views. In the meantime – assum-
ing all can agree that at least some albumin is
filtered – two new intravital imaging studies have
provided important new insights into how this
might be regulated. First, Schiessl et al. [33
&&
] have
shown that in response to angiotensin II infusion,
podocytes can perform megalin-mediated endocy-
tosis of fluorescently labelled albumin, which is
subsequently trafficked across the cell and released
into the urinary space. Interestingly, uptake could
be blocked by an angiotensin II receptor inhibitor,
which could provide a new explanation for an old
observation that these drugs decrease proteinuria in
various glomerular diseases. Meanwhile, Wagner
et al. [34
&&
] have recently suggested that proximal
tubule uptake of albuminmight be regulated, as part
of a homeostatic mechanism to maintain the
plasma concentration in the face of changes in
albumin intake or excretion. In support of this
notion, they found that proximal tubule uptake
decreased when animals were injected with exogen-
ous albumin (a model of systemic albumin excess),
but that it increased in response to podocyte damage
and increased glomerular sieving (a model of
systemic albumin depletion). Although these find-
ings are highly intriguing, the molecular mechan-
ism(s) that could underlie such a regulatory process
remain to be elucidated.
Sepsis and acute kidney injury
Sepsis is a major cause of acute kidney injury (AKI)
and is associated with significant morbidity and
mortality [35]. Unfortunately, our basic understand-
ing of the pathogenesis of septic AKI remains far
from complete, and treatment options are accord-
ingly limited. AKI in sepsis is likely to be a complex
andmultifactorial process, involving dynamic inter-
play between the microvasculature, kidney tubules
and both resident and circulating immune cells [36].
Or to put it another way, a perfect disease to study
with live imaging techniques.
Three fundamental and unresolved questions
continue to dominate the sepsis-AKI field. First, does
tubular damage occur directly (e.g. due to endo-
toxin) or indirectly (e.g. due to reduced oxygen
delivery)? Second, why do patients develop oliguria
Renal immunology and pathology
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even in the absence of clear reductions in renal
blood flow? Third, is the resulting immune response
protective or harmful? Several groups have recently
utilized intravital microscopy to try to answer these
questions. First, Dagher et al. have shown that fluo-
rescently labelled endotoxin [lipopolysaccharide
(LPS)] is filtered by the kidney and taken up in early
(S1) proximal tubule segments [37]. However, rather
than directly causing damage in this segment, evi-
dence of oxidative stress was surprisingly observed
downstream in later S2 segments, perhaps due to
some kind of crosstalk process, involving paracellu-
lar communication. Meanwhile, another group
have shown that LPS causes a reduction in tubular
flow rate, in the absence of a fall in either blood
pressure or glomerular filtration rate, which can
only be partially overcome by supplementation
with intravenous fluids [38
&&
]. Decreased tubular
flow could be explained, at least in part, due to
proximal tubule cell swelling and partial luminal
obstruction. Finally, two recent studies have looked
at the role of immune cells. In a follow-up study to
the one previously mentioned, Dagher et al. showed
that preconditioning with small doses of endotoxin
protects against subsequent oxidative stress in prox-
imal tubules and that this effect requires macro-
phages, which increase in number in the kidney
during sepsis and cluster around proximal tubules
[39
&&
]. Using a caecal ligation and puncture model,
Chousterman et al. also showed that circulating
monocytes infiltrate the kidney and appear to have
a protective effect, adhering to the vasculature in a
process that is dependent on the chemokine recep-
tor CX3CR1 [40
&&
].
Taken together, these findings suggest thatAKI in
sepsis does involve direct tubular toxicity, which
could in part explain reductions in urine flow, and
that immune cells can have a protective role in
response to injury. Further work will be required to
definitively confirm or refute these tentative con-
clusions, but in the meantime these studies nicely
illustrate the power of intravital microscopy to help
elucidatecomplexpathologicalprocesses inreal time,
involving multiple different interacting cell types.
CONCLUSION AND FUTURE DIRECTIONS
With a few notable exceptions, it could be argued
that translational kidney research is failing in gen-
eral, especially in diseases such as AKI, with negative
clinical trials currently greatly outnumbering the
positive [41]. Concurrent with this – and surely
not coincidental – is the perception of a relative
decline in the standing of basic renal research [42].
To rectify this situation, we need a vastly better
fundamental understanding of how the kidney
works, at both a cellular and whole organ level,
and what exactly changes (and when) in disease
states. To achieve this, we need to move away from
unrepresentative in-vitro models, small datasets
and unsophisticated experimental techniques, and
instead embrace the opportunities offered by the
current whirlwind technological revolution to study
integrative systems biology (or physiology, as it was
once known) in animal models that can realistically
reflect themultilayer complexity of human diseases.
This will inevitably entail a rather more honest
admission of the ongoing pivotal role of animal
experiments in translational research. It is now
demonstrably possible, using intravital microscopy,
to make detailed quantitative measurements of
complex and dynamic cellular processes in the func-
tioning kidney and to assess how they are altered in
real time in pathological states or in response to
putative treatments. Moreover, rapid developments
inmultiple different, but complementary, fields will
all combine to move the frontiers forward even
faster in the future, leading to applications that
are yet to be even imagined. This will bring with
it new challenges, such as how to effectively store
and smartly analyse the vast amount of data that
will be generated. Nevertheless, these are evidently
exciting times for biomedical imaging, and it seems
increasingly likely that we will soon have the tools
to address many intriguing and important unan-
swered questions in kidney research.We just have to
use them.
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